Human Experimentation: Methodologic issues fundamental to clinical trials
Despite their effectiveness in the evaluation of new pharmacological compounds, controlled clinical trials are sometimes inadequate. Using data from the literature as well as from the author's own experience with clinical trials, Human Experimentation: Methodologic Issues Fundamental to Clinica...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Dordrecht
Springer Netherlands
1999
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | Despite their effectiveness in the evaluation of new pharmacological compounds, controlled clinical trials are sometimes inadequate. Using data from the literature as well as from the author's own experience with clinical trials, Human Experimentation: Methodologic Issues Fundamental to Clinical Trials addresses such inadequacies and tries to provide solutions. This work is the first to thoroughly examine these unsolved inadequacies and problems with the design and the execution of clinical trials and, more importantly, to provide solutions for these problems. It is important for anyone who is involved in clinical research: clinicians, pharmacists, biochemists, statisticians, nurses, sponsors, etc., and anyone who is involved in applying results of research to patients, i.e. physicians |
| Beschreibung: | 1 Online-Ressource (120 p) |
| ISBN: | 9789401146630 |
| DOI: | 10.1007/978-94-011-4663-0 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046147233 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1999 |||| o||u| ||||||eng d | ||
| 020 | |a 9789401146630 |9 978-94-011-4663-0 | ||
| 024 | 7 | |a 10.1007/978-94-011-4663-0 |2 doi | |
| 035 | |a (ZDB-2-SME)978-94-011-4663-0 | ||
| 035 | |a (OCoLC)1119103939 | ||
| 035 | |a (DE-599)BVBBV046147233 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 610 |2 23 | |
| 100 | 1 | |a Cleophas, Ton J. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Human Experimentation |b Methodologic issues fundamental to clinical trials |c by Ton J. Cleophas |
| 264 | 1 | |a Dordrecht |b Springer Netherlands |c 1999 | |
| 300 | |a 1 Online-Ressource (120 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a Despite their effectiveness in the evaluation of new pharmacological compounds, controlled clinical trials are sometimes inadequate. Using data from the literature as well as from the author's own experience with clinical trials, Human Experimentation: Methodologic Issues Fundamental to Clinical Trials addresses such inadequacies and tries to provide solutions. This work is the first to thoroughly examine these unsolved inadequacies and problems with the design and the execution of clinical trials and, more importantly, to provide solutions for these problems. It is important for anyone who is involved in clinical research: clinicians, pharmacists, biochemists, statisticians, nurses, sponsors, etc., and anyone who is involved in applying results of research to patients, i.e. physicians | ||
| 650 | 4 | |a Medicine/Public Health, general | |
| 650 | 4 | |a Internal Medicine | |
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Statistics for Life Sciences, Medicine, Health Sciences | |
| 650 | 4 | |a Medicine | |
| 650 | 4 | |a Internal medicine | |
| 650 | 4 | |a Toxicology | |
| 650 | 4 | |a Statistics | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780792358275 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789401146647 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-94-011-4663-0 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031527418 | ||
| 966 | e | |u https://doi.org/10.1007/978-94-011-4663-0 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180486326583296 |
|---|---|
| any_adam_object | |
| author | Cleophas, Ton J. |
| author_facet | Cleophas, Ton J. |
| author_role | aut |
| author_sort | Cleophas, Ton J. |
| author_variant | t j c tj tjc |
| building | Verbundindex |
| bvnumber | BV046147233 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-94-011-4663-0 (OCoLC)1119103939 (DE-599)BVBBV046147233 |
| dewey-full | 610 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 610 - Medicine and health |
| dewey-raw | 610 |
| dewey-search | 610 |
| dewey-sort | 3610 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-94-011-4663-0 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02427nmm a2200469zc 4500</leader><controlfield tag="001">BV046147233</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1999 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789401146630</subfield><subfield code="9">978-94-011-4663-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-94-011-4663-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-94-011-4663-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119103939</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046147233</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cleophas, Ton J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Human Experimentation</subfield><subfield code="b">Methodologic issues fundamental to clinical trials</subfield><subfield code="c">by Ton J. Cleophas</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht</subfield><subfield code="b">Springer Netherlands</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (120 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Despite their effectiveness in the evaluation of new pharmacological compounds, controlled clinical trials are sometimes inadequate. Using data from the literature as well as from the author's own experience with clinical trials, Human Experimentation: Methodologic Issues Fundamental to Clinical Trials addresses such inadequacies and tries to provide solutions. This work is the first to thoroughly examine these unsolved inadequacies and problems with the design and the execution of clinical trials and, more importantly, to provide solutions for these problems. It is important for anyone who is involved in clinical research: clinicians, pharmacists, biochemists, statisticians, nurses, sponsors, etc., and anyone who is involved in applying results of research to patients, i.e. physicians</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine/Public Health, general</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Statistics for Life Sciences, Medicine, Health Sciences</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Internal medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Statistics</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780792358275</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789401146647</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-94-011-4663-0</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031527418</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-94-011-4663-0</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV046147233 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:31Z |
| institution | BVB |
| isbn | 9789401146630 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031527418 |
| oclc_num | 1119103939 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (120 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1999 |
| publishDateSearch | 1999 |
| publishDateSort | 1999 |
| publisher | Springer Netherlands |
| record_format | marc |
| spelling | Cleophas, Ton J. Verfasser aut Human Experimentation Methodologic issues fundamental to clinical trials by Ton J. Cleophas Dordrecht Springer Netherlands 1999 1 Online-Ressource (120 p) txt rdacontent c rdamedia cr rdacarrier Despite their effectiveness in the evaluation of new pharmacological compounds, controlled clinical trials are sometimes inadequate. Using data from the literature as well as from the author's own experience with clinical trials, Human Experimentation: Methodologic Issues Fundamental to Clinical Trials addresses such inadequacies and tries to provide solutions. This work is the first to thoroughly examine these unsolved inadequacies and problems with the design and the execution of clinical trials and, more importantly, to provide solutions for these problems. It is important for anyone who is involved in clinical research: clinicians, pharmacists, biochemists, statisticians, nurses, sponsors, etc., and anyone who is involved in applying results of research to patients, i.e. physicians Medicine/Public Health, general Internal Medicine Pharmacology/Toxicology Statistics for Life Sciences, Medicine, Health Sciences Medicine Internal medicine Toxicology Statistics Erscheint auch als Druck-Ausgabe 9780792358275 Erscheint auch als Druck-Ausgabe 9789401146647 https://doi.org/10.1007/978-94-011-4663-0 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Cleophas, Ton J. Human Experimentation Methodologic issues fundamental to clinical trials Medicine/Public Health, general Internal Medicine Pharmacology/Toxicology Statistics for Life Sciences, Medicine, Health Sciences Medicine Internal medicine Toxicology Statistics |
| title | Human Experimentation Methodologic issues fundamental to clinical trials |
| title_auth | Human Experimentation Methodologic issues fundamental to clinical trials |
| title_exact_search | Human Experimentation Methodologic issues fundamental to clinical trials |
| title_full | Human Experimentation Methodologic issues fundamental to clinical trials by Ton J. Cleophas |
| title_fullStr | Human Experimentation Methodologic issues fundamental to clinical trials by Ton J. Cleophas |
| title_full_unstemmed | Human Experimentation Methodologic issues fundamental to clinical trials by Ton J. Cleophas |
| title_short | Human Experimentation |
| title_sort | human experimentation methodologic issues fundamental to clinical trials |
| title_sub | Methodologic issues fundamental to clinical trials |
| topic | Medicine/Public Health, general Internal Medicine Pharmacology/Toxicology Statistics for Life Sciences, Medicine, Health Sciences Medicine Internal medicine Toxicology Statistics |
| topic_facet | Medicine/Public Health, general Internal Medicine Pharmacology/Toxicology Statistics for Life Sciences, Medicine, Health Sciences Medicine Internal medicine Toxicology Statistics |
| url | https://doi.org/10.1007/978-94-011-4663-0 |
| work_keys_str_mv | AT cleophastonj humanexperimentationmethodologicissuesfundamentaltoclinicaltrials |